Leiomyomas with FH deficiency constitutes a rare but clinically relevant subtype, as pathogenic germline variants in FH predispose to hereditary leiomyomatosis and renal cell cancer (HLRCC). This evidence concerns the gene FH and renal cell adenocarcinoma.